Results 171 to 180 of about 134,252 (360)

Characteristics of Pruritus according to Morphological Phenotype of Psoriasis and Association with Neuropeptides and Interleukin-31 [PDF]

open access: diamond, 2020
Sung‐Min Park   +5 more
openalex   +1 more source

Tropical pruritus

open access: yesThe Brazilian Journal of Infectious Diseases, 2014
Loulergue,Pierre, Mir,Olivier
openaire   +4 more sources

From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review examines the epidemiological shift from hepatitis B virus (HBV) to metabolic dysfunction‐associated steatotic liver disease (MASLD) as the leading cause of cirrhosis globally. It highlights the distinct pathogenic mechanisms between HBV and MASLD cirrhosis and discusses evolving diagnostic tools and therapeutic strategies tailored to the ...
Hanqi Yu   +5 more
wiley   +1 more source

Evaluation of serum levels of neurotrophin 4 and brain-derived nerve growth factor in uremic pruritus patients

open access: yesClinical, Cosmetic and Investigational Dermatology, 2019
Neveen E Sorour,1 Fatma M Elesawy,1 Hala A Tabl,2 Mohammed E Ibrahim,3 Essam M Akl1 1Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Benha, Egypt; 2Department of Microbiology and Immunology, Faculty of ...
Sorour NE   +4 more
doaj  

PRURITUS ANI. [PDF]

open access: bronze, 1911
Alan H. Bennett
openalex   +1 more source

One‐year follow‐up after fractionated ultra‐high‐dose‐rate FLASH radiotherapy in patient with extramammary Paget disease of the scrotum

open access: yesPrecision Radiation Oncology, EarlyView.
An elderly male patient with extramammary Paget disease of the scrotum and multiple metastases was treated with fractionated FLASH‐RT (40 Gy in 5 fractions) in the scrotal lesion. Abstract Objective Ultrahigh‐dose‐rate radiotherapy (FLASH‐RT) has been shown to reduce radiation‐induced normal tissue injury in preclinical studies.
Hui Luo   +14 more
wiley   +1 more source

Analysis of C4 Concentrations to Predict Impact of Patient‐Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 596-605, March 2025.
ABSTRACT Linerixibat, an ileal bile acid transporter (IBAT) inhibitor, is being evaluated for the treatment of pruritus in primary biliary cholangitis (PBC). Diarrhea is commonly reported with this drug class as IBAT inhibition redirects bile acids (BA) to the colon.
Fernando Carreño   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy